[3] [7] As of 2024, retatrutide has no UK marketing authorisation granted by the Medicines and Healthcare products Regulatory Agency (MHRA), and it has not received a marketing authorisation from the European Medicines Agency (EMA)
Abnormal mucosal/vascular patterns reliably mark advanced dysplasia and early esophageal adenocarcinoma
GHK-Cu peptide capsules contain a bioavailable form of the copper tripeptide GHK-Cu, which has garnered attention for its potential skin care benefits including rejuvenating and wound healing properties
L.YeatesT
chronic pancreatitis is on-going, leading to more permanent damage
Using or possessing peptides, without a doctors prescription, carries a maximum penalty of 12 months imprisonment or a $18,500 fine (100 penalty units x current value of $185 from 1 July 2024 to 30 June 2025), as per section 39 of the Medicines, Poisons and Therapeutic Goods Act 2012 (NT)